4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-049244
Chief Financial Officer sold 26,257 shares at $30.00 ($787,710)
- Chief Financial Officer acquired 26,257 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-09-08 | Option exercise | +26,257 | $4.12 | $108,179 | 78,475 | D |
| Catinazzo Thomas Chief Financial Officer | 2022-09-08 | Sale | −26,257 | $30.00 | $787,710 | 52,218 | D |
| Derivatives | |||||||
| Catinazzo Thomas Chief Financial Officer | 2022-09-08 | Option exercise · Stock Option (Right to Buy) | −26,257 | 0 | D | ||
| Open-market sales · 26,257 sh · avg $30.00 · $787,710 | |||||||
Loading xslF345X03/doc4.xml…